Omicron: a drug developer’s perspective

References

• Martin DP, Weaver S, Tegally H, et al. The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages. Cell. 2021;184(20):5189–5200.
   PubMed Web of Science ®Google Scholar
• Bushman M, Kahn R, Taylor BP, et al. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Cell. 2021;184(26):6229–6242.
   Google Scholar
• McCallum M, De Marco A, Lempp FA, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184(9):2332–2347.
   PubMed Web of Science ®Google Scholar
• Javanmardi K, Chou CW, Terrace CI, et al. Rapid characterization of spike variants via mammalian cell surface display. Mol Cell. 2021;81(24):5099–5111.
   Google Scholar
• Parker R, Partridge T, Wormald C, et al. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. 2021;35(8):109179.
   PubMed Web of Science ®Google Scholar
• Nitahara Y, Nakagama Y, Kaku N, et al. High-resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients. Microbio Spectr. 2021;9(3):e0096521.
   PubMed Web of Science ®Google Scholar
• Greaney AJ, Starr TN, Barnes CO, et al. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nature. 2021;12:4196.
   Web of Science ®Google Scholar
• Cameroni E, Saliba C, Bowen JE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021 December 14.
   Google Scholar
• Starr TN, Czudnochowski N, Liu Z, et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021;597(7874):97–102.
   Google Scholar
• Wang Y, Zhang L, Li Q, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron. Emerg Microbes Infect. 2022;11(1):1–5.
   PubMed Web of Science ®Google Scholar
• Haynes WA, Kamath K, Bozekowski J, et al. High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19. Commun Biol. 2021;4:1317.
   PubMed Web of Science ®Google Scholar
• Wilhelm A, Widera M, Grikscheit K, et al. Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies. medRxiv. 2021 Dec 13. DOI:10.1101
   Google Scholar
• Zahradnik J, Marciano S, Shemesh M, et al. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nature Microb. 2021;6:1188–1198.
   PubMed Web of Science ®Google Scholar
• Mourier T, Shuaib M, Hala S, et al. Saudi Arabian SARS-CoV-2 genomes implicate a mutant nucleocapsid protein in modulating host interactions and increased viral load inCOVID-19 patients. medRxiv. 2021 May 10. DOI:10.1101
   Google Scholar
• Starr TN, Greaney AJ, Hilton SK, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constrains on folding and ACE2 binding. Cell. 2020;182:1295–1310.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Zhou Y, Lokugamage KG, et al. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. bioRxiv. 2021 October 15. DOI:10.1101
   Google Scholar
• Redd AD, Nardin A, Kared H, et al. Minimal cross-over between mutations associated with omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals. bioRxiv. 2021 December 9. DOI:10.1101
   PubMedGoogle Scholar
• Whittaker C, Watson OJ, Alvarez-Moreno C, et al. Understanding the potential impact of different drug properties On SARS-CoV-2 transmission and disease burden: A modelling analysis. Clin Infect Dis. 2021 September 21. DOI:10.1093
   Web of Science ®Google Scholar
• Liu Z, VanBlargan LA, Bloyet LM, et al. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. bioRxiv. 2021 January 11. DOI:10.1101
   Google Scholar
• Volz E, Hill V, McCrone JT, et al. Evaluating the effects of SARS- CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2021;184(1):64–75.
   PubMed Web of Science ®Google Scholar